 | • レポートコード：GIR-107A11944 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、TCR療法のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。TCR療法の種類別市場規模（キメラ抗原受容体シグナル伝達、TCRα/βヘテロダイマーシグナル伝達）、用途別市場規模（病院、クリニック・外来センター、がん研究所、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・TCR療法の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Adaptimmune Therapeutics PLC、Immunocore、Medigene、Adaptive Biotechnologies、Lion TCR、TCR2 Therapeutics, Inc.、RootPath、Kite Pharma、Guangzhou Xiangxue Pharmaceutical Co., Ltd、Eureka Therapeutics ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：キメラ抗原受容体シグナル伝達、TCRα/βヘテロダイマーシグナル伝達 ・用途別分析2016年-2026年：病院、クリニック・外来センター、がん研究所、その他 ・TCR療法の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・TCR療法のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・TCR療法のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・TCR療法の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・TCR療法の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The TCR Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global TCR Therapy size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global TCR Therapy market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
TCR Therapy market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Transduction of Chimeric Antigen Receptor
Transduction of TCR α/β Heterodimer
Market segment by Application, can be divided into
Hospitals
Clinics & Ambulatory Centers
Cancer Research Institutes
Others
Market segment by players, this report covers
Adaptimmune Therapeutics PLC
Immunocore
Medigene
Adaptive Biotechnologies
Lion TCR
TCR2 Therapeutics, Inc.
RootPath
Kite Pharma
Guangzhou Xiangxue Pharmaceutical Co., Ltd
Eureka Therapeutics
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe TCR Therapy product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of TCR Therapy, with revenue, gross margin and global market share of TCR Therapy from 2019 to 2021.
Chapter 3, the TCR Therapy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and TCR Therapy market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe TCR Therapy research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Product Overview and Scope of TCR Therapy
1.2 Classification of TCR Therapy by Type
1.2.1 Overview: Global TCR Therapy Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global TCR Therapy Revenue Market Share by Type in 2020
1.2.3 Transduction of Chimeric Antigen Receptor
1.2.4 Transduction of TCR α/β Heterodimer
1.3 Global TCR Therapy Market by Application
1.3.1 Overview: Global TCR Therapy Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospitals
1.3.3 Clinics & Ambulatory Centers
1.3.4 Cancer Research Institutes
1.3.5 Others
1.4 Global TCR Therapy Market Size & Forecast
1.5 Global TCR Therapy Market Size and Forecast by Region
1.5.1 Global TCR Therapy Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global TCR Therapy Market Size by Region, (2016-2021)
1.5.3 North America TCR Therapy Market Size and Prospect (2016-2026)
1.5.4 Europe TCR Therapy Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific TCR Therapy Market Size and Prospect (2016-2026)
1.5.6 South America TCR Therapy Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa TCR Therapy Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 TCR Therapy Market Drivers
1.6.2 TCR Therapy Market Restraints
1.6.3 TCR Therapy Trends Analysis
2 Company Profiles
2.1 Adaptimmune Therapeutics PLC
2.1.1 Adaptimmune Therapeutics PLC Details
2.1.2 Adaptimmune Therapeutics PLC Major Business
2.1.3 Adaptimmune Therapeutics PLC TCR Therapy Product and Solutions
2.1.4 Adaptimmune Therapeutics PLC TCR Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Adaptimmune Therapeutics PLC Recent Developments and Future Plans
2.2 Immunocore
2.2.1 Immunocore Details
2.2.2 Immunocore Major Business
2.2.3 Immunocore TCR Therapy Product and Solutions
2.2.4 Immunocore TCR Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Immunocore Recent Developments and Future Plans
2.3 Medigene
2.3.1 Medigene Details
2.3.2 Medigene Major Business
2.3.3 Medigene TCR Therapy Product and Solutions
2.3.4 Medigene TCR Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Medigene Recent Developments and Future Plans
2.4 Adaptive Biotechnologies
2.4.1 Adaptive Biotechnologies Details
2.4.2 Adaptive Biotechnologies Major Business
2.4.3 Adaptive Biotechnologies TCR Therapy Product and Solutions
2.4.4 Adaptive Biotechnologies TCR Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Adaptive Biotechnologies Recent Developments and Future Plans
2.5 Lion TCR
2.5.1 Lion TCR Details
2.5.2 Lion TCR Major Business
2.5.3 Lion TCR TCR Therapy Product and Solutions
2.5.4 Lion TCR TCR Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Lion TCR Recent Developments and Future Plans
2.6 TCR2 Therapeutics, Inc.
2.6.1 TCR2 Therapeutics, Inc. Details
2.6.2 TCR2 Therapeutics, Inc. Major Business
2.6.3 TCR2 Therapeutics, Inc. TCR Therapy Product and Solutions
2.6.4 TCR2 Therapeutics, Inc. TCR Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 TCR2 Therapeutics, Inc. Recent Developments and Future Plans
2.7 RootPath
2.7.1 RootPath Details
2.7.2 RootPath Major Business
2.7.3 RootPath TCR Therapy Product and Solutions
2.7.4 RootPath TCR Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 RootPath Recent Developments and Future Plans
2.8 Kite Pharma
2.8.1 Kite Pharma Details
2.8.2 Kite Pharma Major Business
2.8.3 Kite Pharma TCR Therapy Product and Solutions
2.8.4 Kite Pharma TCR Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Kite Pharma Recent Developments and Future Plans
2.9 Guangzhou Xiangxue Pharmaceutical Co., Ltd
2.9.1 Guangzhou Xiangxue Pharmaceutical Co., Ltd Details
2.9.2 Guangzhou Xiangxue Pharmaceutical Co., Ltd Major Business
2.9.3 Guangzhou Xiangxue Pharmaceutical Co., Ltd TCR Therapy Product and Solutions
2.9.4 Guangzhou Xiangxue Pharmaceutical Co., Ltd TCR Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Guangzhou Xiangxue Pharmaceutical Co., Ltd Recent Developments and Future Plans
2.10 Eureka Therapeutics
2.10.1 Eureka Therapeutics Details
2.10.2 Eureka Therapeutics Major Business
2.10.3 Eureka Therapeutics TCR Therapy Product and Solutions
2.10.4 Eureka Therapeutics TCR Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Eureka Therapeutics Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global TCR Therapy Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 TCR Therapy Players Market Share
3.2.2 Top 10 TCR Therapy Players Market Share
3.2.3 Market Competition Trend
3.3 TCR Therapy Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global TCR Therapy Revenue and Market Share by Type (2016-2021)
4.2 Global TCR Therapy Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global TCR Therapy Revenue Market Share by Application (2016-2021)
5.2 TCR Therapy Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America TCR Therapy Revenue by Type (2016-2026)
6.2 North America TCR Therapy Revenue by Application (2016-2026)
6.3 North America TCR Therapy Market Size by Country
6.3.1 North America TCR Therapy Revenue by Country (2016-2026)
6.3.2 United States TCR Therapy Market Size and Forecast (2016-2026)
6.3.3 Canada TCR Therapy Market Size and Forecast (2016-2026)
6.3.4 Mexico TCR Therapy Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe TCR Therapy Revenue by Type (2016-2026)
7.2 Europe TCR Therapy Revenue by Application (2016-2026)
7.3 Europe TCR Therapy Market Size by Country
7.3.1 Europe TCR Therapy Revenue by Country (2016-2026)
7.3.2 Germany TCR Therapy Market Size and Forecast (2016-2026)
7.3.3 France TCR Therapy Market Size and Forecast (2016-2026)
7.3.4 United Kingdom TCR Therapy Market Size and Forecast (2016-2026)
7.3.5 Russia TCR Therapy Market Size and Forecast (2016-2026)
7.3.6 Italy TCR Therapy Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific TCR Therapy Revenue by Type (2016-2026)
8.2 Asia-Pacific TCR Therapy Revenue by Application (2016-2026)
8.3 Asia-Pacific TCR Therapy Market Size by Region
8.3.1 Asia-Pacific TCR Therapy Revenue by Region (2016-2026)
8.3.2 China TCR Therapy Market Size and Forecast (2016-2026)
8.3.3 Japan TCR Therapy Market Size and Forecast (2016-2026)
8.3.4 South Korea TCR Therapy Market Size and Forecast (2016-2026)
8.3.5 India TCR Therapy Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia TCR Therapy Market Size and Forecast (2016-2026)
8.3.7 Australia TCR Therapy Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America TCR Therapy Revenue by Type (2016-2026)
9.2 South America TCR Therapy Revenue by Application (2016-2026)
9.3 South America TCR Therapy Market Size by Country
9.3.1 South America TCR Therapy Revenue by Country (2016-2026)
9.3.2 Brazil TCR Therapy Market Size and Forecast (2016-2026)
9.3.3 Argentina TCR Therapy Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa TCR Therapy Revenue by Type (2016-2026)
10.2 Middle East & Africa TCR Therapy Revenue by Application (2016-2026)
10.3 Middle East & Africa TCR Therapy Market Size by Country
10.3.1 Middle East & Africa TCR Therapy Revenue by Country (2016-2026)
10.3.2 Turkey TCR Therapy Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia TCR Therapy Market Size and Forecast (2016-2026)
10.3.4 UAE TCR Therapy Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global TCR Therapy Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global TCR Therapy Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market TCR Therapy Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global TCR Therapy Revenue (USD Million) by Region (2016-2021)
Table 5. Global TCR Therapy Revenue Market Share by Region (2021-2026)
Table 6. Adaptimmune Therapeutics PLC Corporate Information, Head Office, and Major Competitors
Table 7. Adaptimmune Therapeutics PLC Major Business
Table 8. Adaptimmune Therapeutics PLC TCR Therapy Product and Solutions
Table 9. Adaptimmune Therapeutics PLC TCR Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Immunocore Corporate Information, Head Office, and Major Competitors
Table 11. Immunocore Major Business
Table 12. Immunocore TCR Therapy Product and Solutions
Table 13. Immunocore TCR Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Medigene Corporate Information, Head Office, and Major Competitors
Table 15. Medigene Major Business
Table 16. Medigene TCR Therapy Product and Solutions
Table 17. Medigene TCR Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Adaptive Biotechnologies Corporate Information, Head Office, and Major Competitors
Table 19. Adaptive Biotechnologies Major Business
Table 20. Adaptive Biotechnologies TCR Therapy Product and Solutions
Table 21. Adaptive Biotechnologies TCR Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Lion TCR Corporate Information, Head Office, and Major Competitors
Table 23. Lion TCR Major Business
Table 24. Lion TCR TCR Therapy Product and Solutions
Table 25. Lion TCR TCR Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. TCR2 Therapeutics, Inc. Corporate Information, Head Office, and Major Competitors
Table 27. TCR2 Therapeutics, Inc. Major Business
Table 28. TCR2 Therapeutics, Inc. TCR Therapy Product and Solutions
Table 29. TCR2 Therapeutics, Inc. TCR Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. RootPath Corporate Information, Head Office, and Major Competitors
Table 31. RootPath Major Business
Table 32. RootPath TCR Therapy Product and Solutions
Table 33. RootPath TCR Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Kite Pharma Corporate Information, Head Office, and Major Competitors
Table 35. Kite Pharma Major Business
Table 36. Kite Pharma TCR Therapy Product and Solutions
Table 37. Kite Pharma TCR Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Guangzhou Xiangxue Pharmaceutical Co., Ltd Corporate Information, Head Office, and Major Competitors
Table 39. Guangzhou Xiangxue Pharmaceutical Co., Ltd Major Business
Table 40. Guangzhou Xiangxue Pharmaceutical Co., Ltd TCR Therapy Product and Solutions
Table 41. Guangzhou Xiangxue Pharmaceutical Co., Ltd TCR Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Eureka Therapeutics Corporate Information, Head Office, and Major Competitors
Table 43. Eureka Therapeutics Major Business
Table 44. Eureka Therapeutics TCR Therapy Product and Solutions
Table 45. Eureka Therapeutics TCR Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Global TCR Therapy Revenue (USD Million) by Players (2019-2021)
Table 47. Global TCR Therapy Revenue Share by Players (2019-2021)
Table 48. Breakdown of TCR Therapy by Company Type (Tier 1, Tier 2 and Tier 3)
Table 49. TCR Therapy Players Head Office, Products and Services Provided
Table 50. TCR Therapy Mergers & Acquisitions in the Past Five Years
Table 51. TCR Therapy New Entrants and Expansion Plans
Table 52. Global TCR Therapy Revenue (USD Million) by Type (2016-2021)
Table 53. Global TCR Therapy Revenue Share by Type (2016-2021)
Table 54. Global TCR Therapy Revenue Forecast by Type (2021-2026)
Table 55. Global TCR Therapy Revenue by Application (2016-2021)
Table 56. Global TCR Therapy Revenue Forecast by Application (2021-2026)
Table 57. North America TCR Therapy Revenue by Type (2016-2021) & (USD Million)
Table 58. North America TCR Therapy Revenue by Type (2021-2026) & (USD Million)
Table 59. North America TCR Therapy Revenue by Application (2016-2021) & (USD Million)
Table 60. North America TCR Therapy Revenue by Application (2021-2026) & (USD Million)
Table 61. North America TCR Therapy Revenue by Country (2016-2021) & (USD Million)
Table 62. North America TCR Therapy Revenue by Country (2021-2026) & (USD Million)
Table 63. Europe TCR Therapy Revenue by Type (2016-2021) & (USD Million)
Table 64. Europe TCR Therapy Revenue by Type (2021-2026) & (USD Million)
Table 65. Europe TCR Therapy Revenue by Application (2016-2021) & (USD Million)
Table 66. Europe TCR Therapy Revenue by Application (2021-2026) & (USD Million)
Table 67. Europe TCR Therapy Revenue by Country (2016-2021) & (USD Million)
Table 68. Europe TCR Therapy Revenue by Country (2021-2026) & (USD Million)
Table 69. Asia-Pacific TCR Therapy Revenue by Type (2016-2021) & (USD Million)
Table 70. Asia-Pacific TCR Therapy Revenue by Type (2021-2026) & (USD Million)
Table 71. Asia-Pacific TCR Therapy Revenue by Application (2016-2021) & (USD Million)
Table 72. Asia-Pacific TCR Therapy Revenue by Application (2021-2026) & (USD Million)
Table 73. Asia-Pacific TCR Therapy Revenue by Region (2016-2021) & (USD Million)
Table 74. Asia-Pacific TCR Therapy Revenue by Region (2021-2026) & (USD Million)
Table 75. South America TCR Therapy Revenue by Type (2016-2021) & (USD Million)
Table 76. South America TCR Therapy Revenue by Type (2021-2026) & (USD Million)
Table 77. South America TCR Therapy Revenue by Application (2016-2021) & (USD Million)
Table 78. South America TCR Therapy Revenue by Application (2021-2026) & (USD Million)
Table 79. South America TCR Therapy Revenue by Country (2016-2021) & (USD Million)
Table 80. South America TCR Therapy Revenue by Country (2021-2026) & (USD Million)
Table 81. Middle East & Africa TCR Therapy Revenue by Type (2016-2021) & (USD Million)
Table 82. Middle East & Africa TCR Therapy Revenue by Type (2021-2026) & (USD Million)
Table 83. Middle East & Africa TCR Therapy Revenue by Application (2016-2021) & (USD Million)
Table 84. Middle East & Africa TCR Therapy Revenue by Application (2021-2026) & (USD Million)
Table 85. Middle East & Africa TCR Therapy Revenue by Country (2016-2021) & (USD Million)
Table 86. Middle East & Africa TCR Therapy Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. TCR Therapy Picture
Figure 2. Global TCR Therapy Revenue Market Share by Type in 2020
Figure 3. Transduction of Chimeric Antigen Receptor
Figure 4. Transduction of TCR α/β Heterodimer
Figure 5. TCR Therapy Revenue Market Share by Application in 2020
Figure 6. Hospitals Picture
Figure 7. Clinics & Ambulatory Centers Picture
Figure 8. Cancer Research Institutes Picture
Figure 9. Others Picture
Figure 10. Global TCR Therapy Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 11. Global TCR Therapy Revenue and Forecast (2016-2026) & (USD Million)
Figure 12. Global TCR Therapy Revenue Market Share by Region (2016-2026)
Figure 13. Global TCR Therapy Revenue Market Share by Region in 2020
Figure 14. North America TCR Therapy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Europe TCR Therapy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Asia-Pacific TCR Therapy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. South America TCR Therapy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Middle East and Africa TCR Therapy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. TCR Therapy Market Drivers
Figure 20. TCR Therapy Market Restraints
Figure 21. TCR Therapy Market Trends
Figure 22. Adaptimmune Therapeutics PLC Recent Developments and Future Plans
Figure 23. Immunocore Recent Developments and Future Plans
Figure 24. Medigene Recent Developments and Future Plans
Figure 25. Adaptive Biotechnologies Recent Developments and Future Plans
Figure 26. Lion TCR Recent Developments and Future Plans
Figure 27. TCR2 Therapeutics, Inc. Recent Developments and Future Plans
Figure 28. RootPath Recent Developments and Future Plans
Figure 29. Kite Pharma Recent Developments and Future Plans
Figure 30. Guangzhou Xiangxue Pharmaceutical Co., Ltd Recent Developments and Future Plans
Figure 31. Eureka Therapeutics Recent Developments and Future Plans
Figure 32. Global TCR Therapy Revenue Share by Players in 2020
Figure 33. TCR Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 34. Global Top 3 Players TCR Therapy Revenue Market Share in 2020
Figure 35. Global Top 10 Players TCR Therapy Revenue Market Share in 2020
Figure 36. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 37. Global TCR Therapy Revenue Share by Type in 2020
Figure 38. Global TCR Therapy Market Share Forecast by Type (2021-2026)
Figure 39. Global TCR Therapy Revenue Share by Application in 2020
Figure 40. Global TCR Therapy Market Share Forecast by Application (2021-2026)
Figure 41. North America TCR Therapy Sales Market Share by Type (2016-2026)
Figure 42. North America TCR Therapy Sales Market Share by Application (2016-2026)
Figure 43. North America TCR Therapy Revenue Market Share by Country (2016-2026)
Figure 44. United States TCR Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Canada TCR Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Mexico TCR Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Europe TCR Therapy Sales Market Share by Type (2016-2026)
Figure 48. Europe TCR Therapy Sales Market Share by Application (2016-2026)
Figure 49. Europe TCR Therapy Revenue Market Share by Country (2016-2026)
Figure 50. Germany TCR Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. France TCR Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. United Kingdom TCR Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Russia TCR Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Italy TCR Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Asia-Pacific TCR Therapy Sales Market Share by Type (2016-2026)
Figure 56. Asia-Pacific TCR Therapy Sales Market Share by Application (2016-2026)
Figure 57. Asia-Pacific TCR Therapy Revenue Market Share by Region (2016-2026)
Figure 58. China TCR Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Japan TCR Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. South Korea TCR Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. India TCR Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Southeast Asia TCR Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Australia TCR Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. South America TCR Therapy Sales Market Share by Type (2016-2026)
Figure 65. South America TCR Therapy Sales Market Share by Application (2016-2026)
Figure 66. South America TCR Therapy Revenue Market Share by Country (2016-2026)
Figure 67. Brazil TCR Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Argentina TCR Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Middle East and Africa TCR Therapy Sales Market Share by Type (2016-2026)
Figure 70. Middle East and Africa TCR Therapy Sales Market Share by Application (2016-2026)
Figure 71. Middle East and Africa TCR Therapy Revenue Market Share by Country (2016-2026)
Figure 72. Turkey TCR Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Saudi Arabia TCR Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. UAE TCR Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Methodology
Figure 76. Research Process and Data Source
世界のキメラ抗原受容体細胞療法市場 2021：企業別、地域別、種類・用途別 The Chimeric Antigen Receptor Cell Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization…- 世界の陽子線治療市場 2021：企業別、地域別、種類・用途別 The Proton Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, rec…
- 世界の補助療法市場 2021：企業別、地域別、種類・用途別 The Adjuvant Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, r…
- 世界の中枢神経系疾患用遺伝子治療市場 2021：企業別、地域別、種類・用途別 The Gene Therapy for CNS Disorders market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade …
- 世界の長寿・老化防止療法市場 2021：企業別、地域別、種類・用途別 The Longevity and Anti-senescence Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization,…